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Abstract
Background: Only 50% of gallbladder cancers (GBC)
are recognized before operation and the remaining tu-
mors are diagnosed during surgery or afterwards by
the pathologist. These situations may demand substan-
tial modifications of the proceeding during surgery as
well as the need for reoperation in some cases. There-
fore, the time of diagnosis may strongly influence the
surgical management of GBC and the prognosis of
the patients.
Methods: Records and follow- up of 152 patients with
gallbladder carcinoma who underwent surgery be-
tween 1980 and 2004 were examined according to the
time of diagnosis, TNM staging system, surgical pro-
cedures, morbidity and predictors of survival. There
were 76 patients with preoperative diagnosis of GBC
(50%; group1), 44 patients with intraoperative diagno-
sis (29%; group 2) and 32 patients (21%; group 3) with
postoperatively incidental finding of GBC. In all cases
radical resection of the GBC was intended, except in 5
patients from group 1. Surgical procedures comprised
from simple cholecystectomy to multivisceral resec-
tions.
Results: Overall 5-year survival rate was 7% with a sig-
nificantly better median survival in group 3 (53.2
month), when compared to only 6.1 month (group 2)
and 5.4 month (group 1), respectively. Findings at op-
eration forced significant modifications of the surgical
strategy in 85%. Complete resection of GBC was
achieved in 38% of the patients. Stage- dependent sur-
vival was comparable between the groups following
R0 resection. Tumor stage, in particular the nodal sta-
tus and radicality of the procedure, but not the time of
diagnosis were the most powerful predictors of out-
come.
Conclusions: Complete tumor resection may provide
long-term survival even in locally advanced GBC. Al-
though the time of diagnosis of GBC causes signifi-
cant changes of the intended procedures during and
after surgery, it has no influence on the prognosis pro-
vided that radical (R0) resection was accomplished.
Key words: Gallbladder cancer, Surgery, Follow up, Pro-
gnosis
Abbreviations: GBC, Gallbladder Carcinoma
INTRODUCTION
Gallbladder carcinoma has a poor prognosis. Five-year
survival ranges between 5% and 13% with a median
survival of less than 6 month [1, 2]. Because tumor
growth is often locally advanced at the time of
surgery, no marked improvement of patients outcome
was achieved during the last decade [4]. Therefore,
once GBC is diagnosed, curative resection can be ex-
pected only in 20-40% of patients [3, 4]. Recent stud-
ies suggest the efficacy of a radical approach to en-
hance survival even in patients with advanced tumor
stages [5-7]. However, these reports need careful eval-
uation because the prognosis strongly depends on the
chance to achieve complete tumor resection (R0) [8,
9].
It is specific for GBC that only about 50% of the
tumors are recognized before an operation [10]. Then,
most of the cancers are unresectable due to local or
distant tumor growth. Although some studies advocat-
ed radical resection in advanced-stage disease, there is
no consensus as to the selection of patients consid-
ered for surgery [10]. In contrast, intra- or postopera-
tive findings of GBC were usually associated with
smaller tumors and a better prognosis, even though re-
cent literature could demonstrate that preoperative di-
agnostic workup may fail to predict GBC also in tu-
mor stages T3 and T4 [11, 12]. Particularly with regard
to incidental GBC findings by the pathologist, the de-
bate continues about the adequate stage-dependent tu-
mor therapy, when the patients age, morbidity of sec-
ondary procedures and 5-year survival rates are taken
into account. Therefore, the commonness of inciden-
tal GBC, either as an intra- or postoperative finding
lies in the need for a substantial switch of the opera-
tive strategy during surgery, i.e. from simple cholecys-
tectomy to extended liver resection, or in the need for
stratifying patients after removal of the gallbladder to
more aggressive, secondary procedures [13-16].
The rarity of GBC limits the ability to perform
prospective, randomized studies of therapy. However,
there is good evidence from numerous retrospective
surveys that tumor stage and radical surgery (R0) are
the strongest predictors of survival [17-19]. The pur-
pose of this study is to provide data, how the time of
diagnosis of GBC may influence surgical procedures
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lowing radical resection.
PATIENTS AND METHODS
Between 1980 and 2004, 196 consecutive patients with
GBC were seen at the Surgical Department of the
University of Munich. Of these, 165 patients under-
went surgery, but only 152 patients were eligible for
follow up until July 2006 (Fig. 1). In another 31 pa-
tients (16%), metastatic disease of GBC was con-
firmed by biopsies at presentation, yielding a total of
152 patients for data analysis. Mean age was 66.3 years
(38-92 years) and there were 93 woman and 59 men in
this study (Table 1). Data was collected from chart re-
view and a telephone questionnaire, including patient
demographics, laboratory data, operative management,
surgical morbidity, pathologic findings, and length of
hospital stay. Histologic examination revealed adeno-
carcinoma in 141 patients (93%), adenosquamous tu-
mors in 7, and squamous carcinoma in 4 patients.
Demographic data as well as the comorbidity of pa-
tients were comparable between the groups. The major-
ity of patients showed ASA 1/2 score (72%) and liver
cirrhosis was absent in most cases (93%). Data about
malignant tumors in the history of some patients in-
cluded breast cancer (3), prostate cancer (3), and
colonic cancer (1) and at the time of admission to our
institution, there was no evidence for local or metastat-
ic recurrence of these cancers. GBC was staged accord-
ing to the TNM classification (UICC; Table 1) [20].
Only 26 patients (17%) had tumors limited to the
gallbladder wall (T1a, n = 5; T1b, n = 9; T2, n = 12)
and all of these were recognized only by the patholo-
gist. The remaining patients (n = 126) had locally ad-
vanced or metastatic cancer.
The most common symptom at presentation was
pain (87%; no difference between the groups). In con-
trast, mild jaundice (64%) and weight loss (31%) were
predominantly present in group 1 (p<0.05 vs. groups
2 and 3). Ninety-four percent of tumors were associ-
ated with gallstones. Therefore, routine laboratory
tests prior to the operation did not markedly help to
identify GBC (Table 2).
The surgical procedure in patients with presumed
benign disease was simple cholecystectomy (SCE), ei-
ther as an open or laparoscopic operation. Early stages
of GBC were treated by an “extended cholecystecto-
my” (ECE) which consisted of an en-bloc removal of
the gallbladder with hepatic wedge resection of seg-
ments IVb/V, and lymphnode dissection of the liga-
ment. Locally advanced cancers with infiltration of the
liver underwent extended liver resection (ELR) and
lymphnode dissection of the ligament. In case of in-
volvement by the GBC, bile duct resection (BDR),
lymphnode dissection and hepatico-jejunostomy was
performed. In some patients multivisceral resections
(MVR) were done to achieve radicality. Only laparoto-
my or palliative surgery was performed when unre-
sectability was suspected. Survival was calculated by
the Kaplan-Meier method. Cox univariate and multi-
variate analysis was performed to determine prognos-
tic factors for survival.
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Fig. 1. Management of all patients presenting with gallblad-
der cancer at our institution.
Note: Patients with serious metastatic disease were excluded
from the study because of proven unresectability. Group 1
also contained patients with local metastatic spread which,
based on preoperative imaging, was assumed to be suitable
for radical resection.
Table 1. TNM (UICC) staging of GBC by time of diagnosis.
Note: In UICC stages I and II GBC is
limited to the gallbladder wall (I: T1a/b;
II: T2), in UICC stage III lymphnodes are
positive (T1-3), in UICC IVa the tumor is
locally destructive (T4), and in UICC
stage IVb local or distant metastases are
present.
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INDICATIONS AND PROCEDURES
Seventy-six patients out of 152 (50%) were admitted
to our institution because of a presumed benign dis-
ease. Most of these had gallbladder stones (n = 71))
and others had concomitant acute (n = 13) or chronic
cholecystitis (n = 21). Diagnostic procedures com-
prised ultrasound in all patients of this group whereas
CT or MRI scans were considered necessary prior to
the operation only in 16 patients (21%). All 76 patients
were subjected to simple cholecystectomy (27 laparo-
scopic and 49 open procedures).
The pathologist recognized GBC postoperatively in
32 patients (group3) whilst the surgeons did not ap-
praise any of these gallbladders suspicious for cancer
(Table 3). Fourteen patients had stage I- tumors (T1a,
n = 5; T1b, n = 9) and 12 patients were classified as
stage II- tumors. Three patients had positive lymph-
nodes at the cystic duct (stage III) while the carcinoma
was limited to the gallbladder wall (T2) and 3 more pa-
tients had T3 cancers (one R1 resection). Although the
indication for a second procedure was defined as T-
stage ≥T1b, or positive resection margins after SCE,
only 12 patients (48%) underwent definitive cancer
surgery.
In 44 patients (group 2) GBC was found inciden-
tally at operation and all of them had already ad-
vanced tumor stages (Table 1). Twenty patients were
considered unresectable due to bulky lymphnodes in
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Table 2. Laboratory data at admission to our institution.
Note: * group 3 vs. group 1; ** group 1
vs. groups 2 and 3.
Table 3. Intended and performed operations (first procedure) by time of diagnosis.
Note: SCE, simple chole-
cystectomy; ECE, extend-
ed cholecystectomy; ELR,
extended liver resection;
BDR, bile duct resection;
MVR, multivisceral resec-
tion; PALL, palliative pro-
cedures; LAP, only laparo-
tomy; Chol., Cholecystitis.
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peritoneal implants of the GBC (n = 6). In the
remaining patients, the surgical strategy was changed
immediately at operation and radical resection of the
tumor was attempted. The procedures performed, in-
cluded all options of resective surgery as demonstrat-
ed in Table 3.
The remaining patients (n = 76) presented prior to
surgery pathological findings which were in accor-
dance with GBC disease (group 1). Five patients had
intestinal obstruction as the main symptom and thus
required palliative surgery (Table 3). In contrast, CT-
and MRI findings of the remaining patients with
suspected GBC were evaluated as suitable for a radical
approach. However, in 44 patients of group 1 (58%)
the tumor size and infiltration pattern as well as
the intraoperative detection of distant metastasis
(liver, n = 21; peritoneum, n = 14; liver and peri-
toneum, n = 9) did not allow curation from GBC, and
obliged the surgeon to terminate the operation as a
diagnostic procedure. The remaining patients (n = 32)
underwent radical surgery which was strongly depen-
dent on differential types of local tumor growth
(Table 3).
The R- status, as indicated in Table 3 describes radi-
cality at first operation. Twenty-five patients of group
3 had tumor stages which required re- operation but
only 12 of them were referred to additional surgery. In
that collective, complete tumor resection (R0) was
achieved in all cases (ECE, n = 9; ELR, n = 3). How-
ever, patients with suspected GBC (group 1) had a sig-
nificantly (p<0.05) higher risk for incomplete tumor
control after surgery (83%) when compared to pa-
tients with GBC detected at operation (69%) or as an
incidental finding by the pathologist (3%).
PERIOPERATIVE PARAMETERS
There was no mortality in the study population, al-
though it is sometimes a challenge for the surgical
team as well as the anaesthesiologist to cope with a
radical change of the surgical procedure at operation
[3, 10]. However, as Table 4 indicates there were no
marked differences seen when perioperative data of
groups 1 and 2 are compared. Blood loss as well as the
operating time and complication rates were similar in
both groups, indicating no additional risk for patients
with incidental GBC finding at operation. In all pa-
tients of group 2, a definitive procedure was aimed at
the first operation so that secondary interventions
were avoided. Mean hospital stay was 12.2 days in
group 1 (7-31 days), 11.8 days in group 2 (6-24), and
4.8 days (2-8) in group 3.
SURVIVAL
The overall 1-, 3,- and 5- year survival rates of the 152
patients were dismal with 43%, 24%, and 7%, respec-
tively. This is the result of a highly metastatic potential
of GBC which resulted in lymphnode involvement in
71% and systemic tumor spread in 49% of the ana-
lyzed patients. These advanced tumors did not allow a
cumulative R0 resection rate beyond 38%. As demon-
strated in Table 3, we found a significant correlation
between the time of diagnosis and the radicality (R
status), indicating a poorer chance of complete tumor
resection with respect to the procedures performed.
Figure 2 illustrates the dependency of survival from
the groups. It is clearly demonstrated that in univariate
analysis the time of recognizing GBC has a highly sig-
nificant impact on the probability for survival as
shown by median survival times of 53.2 month (group
3), 6.1 month (group 2), and 5.4 month (group 1).
The median survival for the 94 patients with unre-
sectable tumors (R1/R2) was 5.1 month with only 1
patient alive beyond 2 years (26 month). For those re-
sected, the 1-, 3,- and 5-year survival was 79%, 47%,
and 26%, respectively. Interestingly, when the patients
of groups 1 - 3 who underwent radical tumor resec-
tion (R0) are compared, we found no differences with
regard to the prognosis when GBC was an incidental
finding (Table 5). In contrast, patients with incomplete
tumor resection (R1/2) showed median survival times
of only 4.8 month (R1 resection) and 3.2 month (R2
resection).
As demonstrated in Table 5, the time of diagnosis
has no effect on the outcome of patients once com-
plete tumor resection was possible. This finding was
confirmed in multivariate analysis which showed the
UICC stage (p<0.001) and radicality of the procedure
(p<0.001) as the only independent predictors of sur-
vival. In contrast, the parameter “time of diagnosis”
did not have the power as a prognostic factor of sur-
vival (p = 0.4; Cox regression analysis).
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Table 4. Perioperative parameters and morbidity by groups 1 and 2.
3. Schauer##:Umbruchvorlage  31.07.2009  11:54 Uhr  Seite 348DISCUSSION
Gallbladder carcinoma carries a poor prognosis, and
the only chance for cure lies in early detection and
complete resection. However, the extent of surgical
procedures remains controversial, particularly after in-
cidental findings or in advanced stages of disease [13,
21, 22]. Some reasons for this are the lack of a uni-
form classification of staging systems in previous re-
ports [23-25] and a different use of terms like “ex-
tended cholecystectomy” and „extended resection“
which included various surgical procedures in some
studies [7, 23, 26]. The 5- year survival rate following
surgery for GBC is reported to be 5–13% in the re-
cent literature [1, 2, 27] except a study of a small num-
ber of cases [2]. The aim of our retrospective study
was to highlight the perioperative situation, the sur-
geon is confronted with: (1) ad hoc decision at inci-
dental findings of GBC during operation about the
extent of further procedure, and (2) stratification of
patients with postoperatively found GBC to a second
operation. In particular, it was of interest if the time
of diagnosis may influence radicality of surgical pro-
cedures and the prognosis of patients.
The diagnosis of GBC is difficult because of the
lack of reliable diagnostic methods [11, 12, 28] and the
unspecific symptoms of patients who, to a consider-
able extent presented in this study with gallbladder
stones (94%) or cholecystitis (22%). Furthermore, in
16 out of 92 patients (17%) who underwent CT or
MR imaging prior to the operation GBC was not de-
tected even though T3 and T4 tumors were present.
Laboratory data usually are also of limited significance
as reported earlier and shown in Table 2 [29]. Conse-
quently, it seems specific that GBC is just partly recog-
nized at diagnostic work up before surgery and that
the remaining carcinomas are detected not until as by
the surgeon at operation or by the pathologist there-
after. In this study, GBC was suspected in 50% of the
patients preoperatively, which is in line with recent lit-
erature [10, 30]. In all other cases, diagnosis was made
at the time of surgery (29%) or postoperatively (21%).
There exists evidence in recent literature that tumor
stage and radical resection are significant predictors of
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Fig 2. Survival by time of diagnosis of
GBC.
Note: p<0.001 (group 3 vs. groups 1/2)
and p<0.05 (group 2 vs. group 1).
Table 5. Survival of patients with complete resection (R0) of GBC.
Note: Given are median sur-
vival times.
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tion as to the indication to extended surgery, in partic-
ular when GBC is an incidental finding. We could
demonstrate that the time of diagnosis of GBC has a
strong influence on tumor stages: significantly more
patients with stage III and IV disease were observed in
groups 1 (suspected GBC) and 2 (incidental finding at
operation). Ninety-three percent and 72% had lymph
node involvement in groups 1 and 2, respectively,
whereas only 3% were affected in group 3. Local or
distant metastasis was present in 70% of patients in
group1, 45% (Group 2), and 3% (group 3).
Therefore, it is obvious that the tumor stage directly
impairs the chance for radical cure of the disease.
Consequently, the rates of complete tumor resections
(R0) varied significantly between the groups, showing
the best result in group 3 (R0;100%) and disappoint-
ing results in group 2 (R0;32%), and group 1 (R0;17%)
which is for the most part consistent with earlier work
[28, 32]. The indication to secondary procedures after
SCE was based on data which demonstrated venous,
lymphatic, or perineural tumor invasion also in T1b
stages, although lymph node involvement is rare in T1
stage [33] and some authors refuse additional surgery
[23, 33, 34]. In our series, only 5 patients had T1a dis-
ease and 9 were staged as T1b. All of them were
staged as node- negative. Five patients with T1b stage
underwent a second procedure and no residual tumor
was found. Five- year survival of patients with T1 dis-
ease was 79%. In contrast, we found a 48% risk of
positive nodes as well as a 21% risk of tumor spread
in T2 cases which clearly demands a more radical ap-
proach than SCE [30].
In the present study, only 15% of the operations
were accomplished as intended, the rest of the pa-
tients underwent either a dramatic change of the pro-
cedure or a second intervention. All the more, careful
evaluation of the tumor stage at operation, the age
and prognosis of the diseased patients and the addi-
tional risk of extended resections should be in mind
of the surgeon [27]. Although we had no mortality in
our patients, some indications for extended tumor re-
sections seemed too optimistic with regard to R0 rates
of only 31% in group 2 and 17% in group 1. More-
over, we and others could demonstrate that not only
the tumor stage, but also the pattern of tumor growth,
and consecutively the kind of surgical procedure has a
strong impact on radicality [6]. Infiltration or local tu-
mor spread to the liver usually required ELR whereas
the involvement of the common bile duct demanded
resection and hepatico-jejunostomy. In our series, we
achieved complete resection after ELR in 13 out of 20
cases (65%) compared to only 36% (5/14) following
BDR. From similar findings, Miyazaki et al. developed
a stratification system for patients with significantly
different prognoses due to tumor localization and the
involvement of adjacent organs [32]. Some authors
suggest extended lymphnode resection for radical
treatment of GBC in these cases [6, 8, 23]. However,
we and others [34] precluded patients with proven in-
volvement of coeliac, superior mesenteric and para-
aortic lymph nodes from radical resection because the
prognosis seems similar to metastatic disease [7]. Ex-
tended resections were performed in our series with a
low morbidity which is in line with recent reports,
demonstrating low mortality and complication rates
after major liver resections even in the older popula-
tion [35].
Complete macroscopic and microscopic resection
of the gallbladder including adjacent tissue of various
extent is a prerequisite for long- term survival, partic-
ularly in advanced tumor stages [17, 27]. Our findings
support this contention, demonstrating gross tumor
remnants (R2) as well as microscopically positive tu-
mor margins (R1) as significantly negative predictors
of survival. As we could show that the time of diag-
nosis of GBC strongly influences surgical procedures
and radicality, it was of special interest if survival was
dependent on the time of diagnosis when complete
tumor resection was accomplished. Interestingly, we
observed comparable median and five- year survival
rates, regarding T3 and T4- staged GBC of groups 1
and 2. Patients with T3 cancer had a median survival
time of about 22 month whereas in cases with T4
stage, the prognosis was decreased to approximately
18 month. Taking the median survival of patients
with unresected GBC into account, the survival bene-
fit of those undergoing radical surgery (R0) is almost
about 20 month. Therefore, it seems justified to sub-
ject patients with incidental findings of advanced
GBC to aggressive surgery at the same operation [3],
in particular because of the low morbidity as demon-
strated in this series. We had only 3 patients with T3-
staged GBC in the postoperative findings, one had
positive lymphnodes and another had a single liver
metastasis next to the gallbladder bed. Reoperation
resulted in complete tumor control, but median sur-
vival was also disappointing with 23.4 month. Al-
though there is no group in this study undergoing ob-
servation alone for comparison, it is certain that resid-
ual disease would lead to recurrence and death within
6 month [23].
In conclusion, the present study confirms earlier
reports which demonstrated a significant impact of
the tumor stage and a radical resection of GBC on
survival [27]. This anaylsis additionally proved that the
time of diagnosis has no influence on the prognosis
of patients after radical resection. However, substan-
tial decisions concerning the indication, the framing
of the approach to resection, the expected morbidity
and survival time are requested by the surgeon. Spe-
cial attention has to be drawn in the future on a care-
ful imaging before surgery to avoid R1/R2- resec-
tions.
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